MULTICENTER RETROSPECTIVE ANALYSIS OF THE EFFICACY OF REGORAFENIB AFTER PROGRESSION ON SORAFENIB WITH HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Lee, Min-Jin [1 ]
Chang, Sung Won [1 ]
Lee, Ha Seok [1 ]
Kim, Sehwa [1 ]
Lee, Young-Sun [1 ]
Jung, Young Kul [1 ]
Suh, Sang Jun [1 ]
Kim, Ji Hoon [1 ]
Seo, Yeon Seok [1 ]
Yim, Hyung Joon [1 ]
Yeon, Jong Eun [1 ]
Byun, Kwan Soo [1 ]
机构：
[1] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
377
引用
收藏
页码：239A / 240A
页数：2
相关论文
共 50 条
  • [21] Meta-analysis of the Efficacy of Sorafenib for Hepatocellular Carcinoma
    Wang, Zhao
    Wu, Xiao-Ling
    Zeng, Wei-Zheng
    Xu, Gui-Sen
    Xu, Hui
    Weng, Min
    Hou, Juan -Ni
    Jiang, Ming-De
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (02) : 691 - 694
  • [22] Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability
    Kostner, Anne Helene
    Sorensen, Morten
    Olesen, Rene Krojgaard
    Gronbaek, Henning
    Lassen, Ulrik
    Ladekarl, Morten
    [J]. SCIENTIFIC WORLD JOURNAL, 2013,
  • [23] Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
    Kissel, Maria
    Berndt, Sandra
    Fiebig, Lukas
    Kling, Simon
    Ji, Qunsheng
    Gu, Qingyang
    Lang, Tina
    Hafner, Frank-Thorsten
    Teufel, Michael
    Zopf, Dieter
    [J]. ONCOTARGET, 2017, 8 (63): : 107096 - 107108
  • [24] Determinants of Survival and Post-Progression Outcomes by Sorafenib-Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma
    Lee, I-Cheng
    Chao, Yee
    Lee, Pei-Chang
    Chen, San-Chi
    Chi, Chen-Ta
    Wu, Chi-Jung
    Wu, Kuo-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    [J]. CANCERS, 2022, 14 (08)
  • [25] Efficacy of regorafenib according to extended RAS evaluation: A multicenter retrospective analysis
    Trovato, G.
    Valente, G.
    Calegari, M.
    Dell'Aquila, E.
    Anghelone, A.
    Lucchetti, J.
    Schietroma, F.
    Zurlo, I.
    Signorelli, C.
    Morelli, C.
    Zoratto, F.
    Caira, G.
    Spring, A.
    Saltarelli, R.
    Cosimati, A.
    Schirripa, M.
    Santamaria, F.
    Angotti, L.
    Salvatore, L.
    Pozzo, C.
    Basso, M.
    Tortora, G.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S140 - S141
  • [26] Efficacy and safety of REGORAFENIB in real life in the treatment of hepatocellular carcinoma. Multicenter experience
    Fraile, M.
    Ferrer, M. T.
    Matilla, A. M.
    Lledo, J. L.
    Minguez, B.
    Hernandez, A.
    Perello, C.
    Fernandez-Castroagudin, J.
    de Lope, C. R.
    Aguilar, M. D. E.
    Montoliu, S.
    Sala, M.
    Romero-Gutierrez, M.
    Pascual, S.
    Urquijo, J. J.
    Arraez, D. E. M.
    Rodriguez, M. J. B.
    Varela, M.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S15 - S15
  • [27] Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance
    Zou, Xinhua
    Xu, Qingyu
    You, Ran
    Yin, Guowen
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 267 - 279
  • [28] Analysis of sorafenib-regorafenib sequential therapy in patients with advanced hepatocellular carcinoma using baseline date of sorafenib
    Yumita, Sae
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Kobayashi, Kazufumi
    Maruta, Susumu
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Maeda, Takahiro
    Kusakabe, Yuko
    Kiyono, Soichiro
    Nakamura, Masato
    Saito, Tomoko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E90 - E91
  • [29] Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
    Iavarone, Massimo
    Invernizzi, Federica
    Czauderna, Carolin
    Sanduzzi-Zamparelli, Marco
    Bhoori, Sherrie
    Amaddeo, Giuliana
    Manini, Matteo A.
    Lopez, Miguel F.
    Anders, Margarita
    Pinter, Matthias
    Rodriguez, Maria J. B.
    Cristobal, Mario R.
    Soteras, Gabriel A.
    Pinero, Federico
    Villadsen, Gerda E.
    Weinmann, Arndt
    Crespo, Gonzalo
    Mazzaferro, Vincenzo
    Regnault, Helene
    De Giorgio, Massimo
    Gonzalez-Dieguez, Maria L.
    Donato, Maria F.
    Varela, Maria
    Woerns, Marcus-Alexander
    Bruix, Jordi
    Lampertico, Pietro
    Reig, Maria
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (11) : 3176 - 3184
  • [30] Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study
    Ren, Yanqiao
    Liu, Yiming
    Song, Songlin
    Zheng, Chuansheng
    [J]. CANCER CONTROL, 2024, 31
12345